sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Middle East and Africa Plasma Fractionation Market...

中东和非洲血浆分馏市场预测至 2028 年 - COVID-19 影响和按产品（免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品）、应用（神经病学、免疫学、血液学、重症监护、肺病学）进行区域分析和其他应用程序）和最终用户（医院和诊所、临床研究实验室和学术机构）

TIPRE00026274 | Pages: 123 | Medical Device | Dec 2021 | Type: Regional | Status: Published

市场介绍

阿拉伯联合酋长国（UAE）、沙特阿拉伯和南非是MEA 的 3 个主要国家。 2021 年，沙特阿拉伯是该地区最大的血浆分离市场。MEA 的血浆分离市场预计在预测期内将以 5.2% 的复合年增长率增长；这种增长归因于各种疾病患病率的上升以及该地区政府举措的增加。

经济的不确定性和持续的冲突正在使该地区的状况恶化。例如，叙利亚、利比亚和也门等国家正遭受暴力冲突，无法实施强有力的公共卫生措施。由于美国的制裁，伊朗经济陷入严重衰退。此外，中东国家经济稳定的主要来源是石油生产和出口。然而，COVID-19 大流行正在造成中东经济动荡。国内外对商品和产品（特别是原油）的需求突然下降，以及由于劳动力短缺而导致的生产停顿是该地区受到的重大影响。 COVID-19 在该地区的传播给医疗保健专业人员造成了沉重的负担。心脏外科医生不堪重负，需要进行紧急心脏手术、管理 COVID-19 患者以及实施安全指南以防止病毒传播。病毒的迅速传播影响了择期手术。因此，COVID-19 的爆发对 MEA 血浆分离市场的增长产生了负面影响。     

   
市场概况和动态

血浆分离中东和非洲市场预计将从 2021 年的 24.5561 亿美元增长到 2028 年的 34.9073 亿美元；预计 2021 年至 2028 年复合年增长率为 5.2%。血浆是治疗各种慢性疾病的新兴方法之一。血浆由蛋白质、白蛋白、球蛋白、纤维蛋白原、凝血因子和抑制剂等必需成分组成。它广泛用于血癌、新冠肺炎、心房颤动、白血病等。通过血浆分级分离将血浆从捐献的血液中分离出来。监管机构还为在处理过程中使用等离子体提供所需的批准。因此，监管机构和政府的积极参与和批准有望鼓励血浆的应用。献血后 24 小时内冷冻，血浆可保存长达一年，以保护宝贵的凝血因子，并可在解冻后使用。每个国家都建立了许多血库机构，可以利用医疗服务提供者，并由各国政府和其他组织资助。因此，根据上述因素，预测期内血浆分离相关市场。      

主要细分市场

< MEA 血浆分离市场分为产品、应用、最终用户和国家。 MEA 血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。MEA 血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年，神经病学领域可能会占据最大的市场份额。 MEA 血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年，医院和诊所部门可能会占据最大的市场份额。根据国家/地区，MEA 血浆分馏市场分为沙特阿拉伯、南非、阿联酋和 MEA 的其他地区。中东和非洲其他地区在 2021 年占据了最大的市场份额。

主要来源和上市公司

准备本中东和非洲血浆分馏市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库，其中其他的。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV)；生物制品实验室有限公司；生物测试公司； CSL有限公司；格里福尔斯，SA； Kedrion SpA；奥克塔制药公司；和 SK 等离子。          

原因购买报告

  • 了解 MEA 血浆分馏市场格局并确定最重要的细分市场可能会保证丰厚的回报。
  • 了解 MEA 血浆分馏市场不断变化的竞争格局，保持领先地位。
  • 通过识别最有可能销售的细分市场，有效规划 MEA 血浆分馏市场的并购和合作交易。
  • 帮助从敏锐的洞察力中做出明智的业务决策并对 MEA 血浆分馏市场各个细分市场的市场表现进行综合分析。
  • 获取 MEA 地区 2021-2028 年各个细分市场的市场收入预测。

MEA 血浆分馏市场细分

MEA 血浆分馏市场 - 按产品

  • 免疫球蛋白
    • 静脉注射免疫球蛋白（IVIG）
    • 皮下注射免疫球蛋白（SCIG） )
  • 白蛋白
  • 浓缩凝血因子
  • 蛋白酶抑制剂
  • 其他

MEA 血浆分馏市场- 申请

  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他

MEA 血浆分馏市场 - 结束用户

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

MEA 血浆分馏市场 - 按国家/地区

  • 沙特阿拉伯
  • 南非
  • 阿联酋
  • MEA其他地区

MEA血浆分馏市场 - 公司简介

  • 巴拉特血清和疫苗有限公司 (BSV)
  • 生物制品实验室有限公司
  • Biotest AG。
  • CSL Limited
  • Grifols, SA
  • Kedrion SpA
  • Octapharma AG
  • SK Plasma

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Plasma Fractionation Market – By Product

1.3.2        MEA Plasma Fractionation Market – By Application

1.3.3        MEA Plasma Fractionation Market – By End User

1.3.4        MEA Plasma Fractionation Market – By Country

2.           MEA Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy Getting Popular

5.1.2        Significant Rise in Participation of the Players in Market Developments

5.2         Market Restraints

5.2.1        Various Non-Plasma Substitutes Available

5.3         Market Opportunities

5.3.1        Emerging Countries Showing Development Capability

5.4         Future Trends

5.4.1        Plasma Therapy in the Treatment of Novel Diseases

5.5         Impact Analysis

6.           Plasma Fractionation Market – MEA Analysis

6.1         MEA Plasma Fractionation Market Revenue Forecast and Analysis

7.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         MEA Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    UAE: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.1.4       UAE: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.4.1    UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.3       Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.2.4       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.5       Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.3       South Africa: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    South Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.3.4       South Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.4.1    South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.3       Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.4.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.5       Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on MEA Plasma Fractionation Market

11.1      MEA: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Biotest AG.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Octapharma AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Kedrion S.p.A

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      CSL Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Grifols, S.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio Products Laboratory Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Bharat Serums and Vaccines Limited (BSV)

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      SK Plasma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             UAE: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             UAE: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of MEA: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic developments done by Companies

Table 19.          Glossary of Terms, MEA Plasma Fractionation Market

 


LIST OF FIGURES

Figure 1.           MEA Plasma Fractionation Market Segmentation

Figure 2.           MEA Plasma Fractionation Market Segmentation, By Country

Figure 3.           MEA Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in MEA Plasma Fractionation Market

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           MEA PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to MEA Plasma Fractionation Market

Figure 8.           MEA Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           MEA Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        MEA Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        MEA Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        MEA Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        MEA Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        MEA Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        MEA Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        MEA Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        MEA Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        MEA Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        MEA Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        MEA Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        MEA Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        MEA Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        MEA Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        MEA Plasma Fractionation Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 29.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

Figure 30.        UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        Impact of COVID-19 Pandemic in MEA Country Markets

Figure 35.        Growth Strategies Followed by Major Market Players (%)

  1. Bharat Serums and Vaccines Limited (BSV)
  2. Bio Products Laboratory Ltd.
  3. Biotest AG.
  4. CSL Limited
  5. Grifols, S.A.
  6. Kedrion S.p.A
  7. Octapharma AG
  8. SK Plasma
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA plasma fractionation market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the MEA plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription